SCHEMBL30108652

SCHEMBL30108652

COc1cc(C)ccc1-c1nnc(O)c2cscc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.40
ACHE P22303 1/20 0.38
CRHR1 P34998 1/20 0.36
GUSB P08236 1/20 0.36
SCN9A Q15858 1/20 0.34
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
CYP3A4 P08684 2/20 0.32
GAA P10253 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2E1 P05181 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2A6 P11509 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108839 0.84 ACHE (0.38) NLRP3ACHECRHR1SCN9AKMT2A
SCHEMBL28934716 0.80 ACHE (0.37) ACHECRHR1GUSBSCN9AKMT2A
SCHEMBL26134941 0.79 MAOA (0.37) ACHECRHR1SCN9ASMN1; SMN2CYP2D6
SCHEMBL28934693 0.79 KDM4E (0.38) ACHECRHR1GUSBSCN9AKMT2A
SCHEMBL30108637 0.79 MAOA (0.37) ACHECRHR1GUSBSCN9ASMN1; SMN2
SCHEMBL30108817 0.76 STAT3 (0.35) ACHECRHR1GUSBKMT2AALDH1A1
SCHEMBL28963081 0.76 SCN9A (0.40) CRHR1SCN9A
SCHEMBL30108705 0.75 KMT2A (0.47) KMT2AGAAMAPTSMN1; SMN2NPC1
SCHEMBL30108755 0.75 KMT2A (0.47) KMT2AGAAMAPTSMN1; SMN2NPC1
SCHEMBL30108716 0.73 ACHE (0.38) ACHECRHR1GUSBSCN9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433163-A NLRP3 inflammasome inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2022-12-06 CN disclosed